Friday, December 11, 2015

          UC Hastings & UC Santa Cruz Offer New JD/Masters in Applied Economics & Finance

          Typical enrollee will spend the first two years at UC Hastings, the third year at UC Santa Cruz, and one final semester at UC Hastings.
          Sample alt tag.
          "We focus almost exclusively on applied work: working with data, whether it’s in the context of finance, or economics, so our students come away with a really deep understanding of how economics is applied to data analysis and how to interpret results from data.” - Alan Spearot, UC Santa Cruz Associate Professor of International Economics

          UC Hastings is pleased to announce its newest concurrent degree program, a JD/Masters in Applied Economics and Finance, in coordination with UC Santa Cruz. The program, set to begin Fall ’16 semester, allows students to complete both degrees in three-and-a-half years, less time than if the degrees were pursued serially.

          The point-person for the program is UC Hastings Associate Professor Morris Ratner, who also oversees UC Hastings’ JD/MBA concurrent degree programs with several other universities.

          Noting that UC Hastings and Santa Cruz have already successfully coordinated on programming via the 3+3 joint BA/JD, Professor Ratner said the institutions are well-matched: “Our schools share a number of commitments, to diversity, to social justice, and, also, to rigorous academic programming. It's that latter shared commitment that sets us up nicely for a concurrent degree program in law and economics. The UC Santa Cruz Department of Economics, headed by Professor and Chair Robert W. Fairlie, is consistently highly ranked and regarded.”

          This particular concurrent program seemed a natural fit, said Alan Spearot, UC Santa Cruz Associate Professor of International Economics, who was instrumental in the concurrent program’s inception and will be teaching an Econometrics course in the second quarter, because “Lots of law students are interested in going the corporate route, representing hi-tech firms, as opposed to going into the courtroom. These firms have a ridiculous amount of data, and rely on people who code. We focus almost exclusively on applied work: working with data, whether it’s in the context of finance, or economics, so our students come away with a really deep understanding of how economics is applied to data analysis and how to interpret results from data.”

          The typical enrollee will spend the first two years at UC Hastings, the third year at UC Santa Cruz, and one final semester at UC Hastings. To participate in the program, students must apply directly for admission to UC Santa Cruz. Admissions information can be found here, and program requirements information here. Students who apply to the UC Santa Cruz program should confer with Professor Ratner before applying, and upon admission, for assistance navigating requirements associated with earning multiple degrees concurrently.

          Past graduates of the UC Santa Cruz Masters program have gone on to careers in the private and public sectors with placements at such diverse companies and institutions as: Cisco Systems, Seagate Technology, Google, Sony Computer Entertainment, Plantronics, Securities and Exchange Commission, all of the big four accounting firms, Visa, Square Trade, the California Franchise Tax Board, Blue Cross, the World Bank, Stanford University, and the Bank of Japan.

          Professor Ratner, who joined the UC Hastings faculty in 2012 and teaches a seminar on the business of law practice, stressed that since UC Hastings already has a rich array of business-related courses as part of its regular curriculum, many law students interested in business law need not obtain a second graduate degree in economics or business. “Concurrent degree programs in business or economics best meet the needs of two types of law students: those primarily interested in a business career, where a law degree is useful but not required; and those who want to practice as lawyers, but who also wish to contribute to businesses in other ways, e.g., as corporate officers,” Ratner said.

          For more information about the new concurrent JD/Masters program, and other JD/MBA opportunities, please click here or contact Professor Ratner directly (ratnerm@uchastings.edu).


          The Chip W. Robertson ’98 MBA Access Fund does not apply to this program. 

          Go to News Archive

          Share this Story

          Share via Facebook
          Share via TwitterShare via EmailPrint Friendly Version

          Other Recent Stories/ RSS

          Monday, November 20, 2017

          Professor Carol Izumi receives 2018 William Pincus Award for Outstanding Service and Commitment to Clinical Legal Education from the Association of American Law Schools (AALS)

          “Recipients are giants in the field and Carol belongs in their midst,” says Associate Dean Ascanio Piomelli.
          Friday, November 17, 2017

          Exciting New Spring 2018 Courses Focus on the Future

          Grabbing from the headlines and emphasizing innovation, courses like Legal Tech Startups, Advanced Immigration Law, and Stalking and Law will prepare UC Hastings students for next-level legal careers.
          Tuesday, November 14, 2017

          Port pilot John Betz ’96 discusses his non-legal career and the importance of education

          A tragic “Deadliest Catch” moment piqued a lifelong interest in the law and encouraged John to pursue a law degree at UC Hastings.
          Friday, November 03, 2017

          Thinkers & Doers: October 2017

          100 Things Warriors Fans Should Know & Do Before They Die -- Alum appointed Chargé d’Affaires -- The poisonous dynamic over who’s to blame for racism -- Prof. Williams on the Harvey Weinstein Effect -- Two More UC Hastings Grads Receive Judgeships from Gov. Brown -- Jury selection in the Steinle case -- and much more
          Wednesday, November 01, 2017

          Why do drug prices remain so high?

          "Because drug companies block competition," says Professor Feldman in a new study that examines all drugs on the market between 2005 and 2015, identifying and analyzing every instance in which the company added new patents or exclusivities. 
          Go to News Archive